| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TENAX THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 30,000 | $270,000 | $9.00 | 09 Jan 2026 | Direct |
| Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 6,333 | $53,577 | $8.46 | 28 Mar 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Common Stock | 3,167 | $26,793 | $8.46 | 28 Mar 2025 | Direct |
| TENAX THERAPEUTICS, INC. | Director | Common Stock | 1,993 | $17,937 | $9.00 | 09 Jan 2026 | By Meadowlark Management, LLC |
| BRAINSTORM CELL THERAPEUTICS INC. | Director | Common Stock | 7,175 | $12,729 | $1.77 | 15 Dec 2021 | By Meadowlark Management LLC |
| BRAINSTORM CELL THERAPEUTICS INC. | Director | Common Stock | 6,000 | $10,645 | $1.77 | 15 Dec 2021 | Direct |
| Avalo Therapeutics, Inc. | Director | Common Stock | 1,000 | $8,460 | $8.46 | 28 Mar 2025 | By Meadowlark Management, LLC |
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20,100 | 17 Jun 2025 | Direct | ||
| Actinium Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | 31 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TENX | TENAX THERAPEUTICS, INC. | 09 Jan 2026 | 1 | $0 | 4 | Director | 13 Jan 2026, 20:29 |
| TENX | TENAX THERAPEUTICS, INC. | 17 Nov 2025 | 2 | +$14,945 | 4/A | Director | 20 Nov 2025, 18:16 |
| TENX | TENAX THERAPEUTICS, INC. | 01 Jul 2025 | 1 | $0 | 4 | Director | 03 Jul 2025, 08:14 |
| AVTX | Avalo Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 16:13 |
| ATNM | Actinium Pharmaceuticals, Inc. | 31 Mar 2025 | 1 | $0 | 4 | Director | 02 Apr 2025, 18:22 |
| AVTX | Avalo Therapeutics, Inc. | 28 Mar 2025 | 2 | $0 | 4 | Director | 01 Apr 2025, 16:22 |
| TENX | TENAX THERAPEUTICS, INC. | 10 Dec 2024 | 1 | $0 | 4 | Director | 12 Dec 2024, 19:49 |
| AVTX | Avalo Therapeutics, Inc. | 12 Nov 2024 | 2 | +$12,750 | 4 | Director | 14 Nov 2024, 17:21 |
| ATNM | Actinium Pharmaceuticals, Inc. | 01 Nov 2024 | 1 | $0 | 4 | Director | 05 Nov 2024, 17:12 |
| ATNM | Actinium Pharmaceuticals, Inc. | 01 Nov 2024 | 0 | $0 | 3 | Director | 05 Nov 2024, 17:10 |
| AVTX | Avalo Therapeutics, Inc. | 13 Aug 2024 | 2 | $0 | 4 | Director | 14 Aug 2024, 16:47 |
| AVTX | Avalo Therapeutics, Inc. | 20 Dec 2023 | 1 | $0 | 4 | Director | 21 Dec 2023, 16:04 |
| AVTX | Avalo Therapeutics, Inc. | 30 Jun 2023 | 1 | $0 | 4 | Director | 05 Jul 2023, 16:05 |
| AVTX | Avalo Therapeutics, Inc. | 31 Mar 2023 | 1 | $0 | 4 | Director | 04 Apr 2023, 16:09 |
| AVTX | Avalo Therapeutics, Inc. | 30 Dec 2022 | 1 | $0 | 4 | Director | 03 Jan 2023, 15:11 |
| AVTX | Avalo Therapeutics, Inc. | 30 Sep 2022 | 1 | $0 | 4 | Director | 03 Oct 2022, 16:28 |
| AVTX | Avalo Therapeutics, Inc. | 30 Jun 2022 | 1 | $0 | 4 | Director | 01 Jul 2022, 16:00 |
| AVTX | Avalo Therapeutics, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 16:15 |
| TENX | TENAX THERAPEUTICS, INC. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 20:36 |
| AVTX | Avalo Therapeutics, Inc. | 31 Mar 2022 | 1 | $0 | 4 | Director | 04 Apr 2022, 17:13 |
| AVTX | Avalo Therapeutics, Inc. | 31 Dec 2021 | 1 | $0 | 4 | Director | 04 Jan 2022, 15:28 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 15 Dec 2021 | 1 | $0 | 4 | Director | 17 Dec 2021, 16:02 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 10 Dec 2021 | 1 | $0 | 4 | Director | 10 Dec 2021, 19:00 |
| AVTX | Avalo Therapeutics, Inc. | 10 Nov 2021 | 1 | $0 | 4 | Director | 12 Nov 2021, 15:18 |
| AVTX | Avalo Therapeutics, Inc. | 10 Nov 2021 | 0 | $0 | 3 | Director | 12 Nov 2021, 15:09 |
| TENX | TENAX THERAPEUTICS, INC. | 10 Jun 2021 | 1 | $0 | 4 | Director | 15 Jun 2021, 16:34 |
| TENX | TENAX THERAPEUTICS, INC. | 25 Feb 2021 | 0 | $0 | 3 | Director | 12 Apr 2022, 17:52 |